A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of TNP-2198 Capsules in Asymptomatic Participants With Helicobacter Pylori Infection
Clinical trial NCT06081712 · COMPLETED
Trial details
- NCT number
- NCT06081712
- Sponsor
- TenNor Therapeutics (Suzhou) Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-20
- Primary completion
- 2021-07-15
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.